phenacetin has been researched along with primaquine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Draheim, R; Holmén, AG; Wassvik, CM | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Akintonwa, DA | 1 |
| La Du, BN | 1 |
| Edwards, A; Gupta, JD; Harley, JD | 1 |
| Fraser, IM; Tilton, BE; Vesell, ES | 1 |
| Waser, PG | 1 |
| Harley, JD | 1 |
1 review(s) available for phenacetin and primaquine
| Article | Year |
|---|---|
Genetic determimants in drug action.
Topics: Acetylation; Acetyltransferases; Cholinesterases; Coumarins; Dealkylation; Drug Resistance; Genes; Genetics, Medical; Glucosephosphate Dehydrogenase Deficiency; Guanine; Humans; Isoniazid; Liver; Metabolism, Inborn Errors; Methemoglobinemia; Models, Biological; Pedigree; Pentosyltransferases; Pharmacology; Phenacetin; Primaquine; Succinylcholine | 1972 |
13 other study(ies) available for phenacetin and primaquine
| Article | Year |
|---|---|
Molecular characteristics for solid-state limited solubility.
Topics: Chemical Phenomena; Chemistry, Physical; Molecular Structure; Multivariate Analysis; Pharmaceutical Preparations; Regression Analysis; Solubility | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The derivation of nitrosamines from some therapeutic amines in the human environment.
Topics: Amines; Carcinogens; Chemical Phenomena; Chemistry; Chloroquine; Chlorpromazine; Humans; Methadone; Mixed Function Oxygenases; Nitrosamines; Pharmaceutical Preparations; Phenacetin; Primaquine | 1985 |
Photomicrographic evaluation of drug-induced cataracts in cultured embryonic chick lens.
Topics: Animals; Cataract; Chick Embryo; Chloroquine; Culture Media; Culture Techniques; Hydroquinones; Lens, Crystalline; Naphthols; Naphthoquinones; Ouabain; Phenacetin; Phenobarbital; Phenylbutazone; Phenylhydrazines; Photomicrography; Prednisolone; Primaquine; Pyrogallol; Sulfanilamides; Vitamin K | 1973 |
Alterations in normal and G-6-PD deficient human erythrocytes of various ages after exposure to metabolites of hemolytic drugs.
Topics: Adult; Erythrocyte Aging; Erythrocytes; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Hemolysis; Humans; Male; Methemoglobinemia; Phenacetin; Primaquine; Time Factors | 1971 |
[Pharmacogenetics].
Topics: Anemia, Hemolytic; Antipyrine; DNA; Drug-Related Side Effects and Adverse Reactions; Europe; Glucosephosphate Dehydrogenase Deficiency; Glutathione; Humans; Isoniazid; Pharmacogenetics; Phenacetin; Polyneuropathies; Primaquine; Quinine; Racial Groups; Sulfonamides | 1967 |
Hemolytic anemia complicating viral hepatitis and G-6-PD deficiency.
Topics: Anemia, Hemolytic; Anemia, Hemolytic, Congenital; Aspirin; Glucosephosphate Dehydrogenase Deficiency; Hepatitis A; Humans; Metabolism, Inborn Errors; Phenacetin; Primaquine; Probenecid | 1969 |
Significance and regulation of methaemoglobinaemia.
Topics: Aspirin; Erythrocytes; Glutathione; Hemolysin Proteins; Methemoglobin; Methylene Blue; Naphthalenes; Naphthoquinones; Nitrites; Phenacetin; Phenols; Phenylhydrazines; Primaquine; Quinones | 1966 |